These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9698042)

  • 1. Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats.
    Isaji M; Miyata H; Ajisawa Y; Yoshimura N
    Life Sci; 1998; 63(4):PL71-4. PubMed ID: 9698042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S; Takagi H; Otani A; Suzuma K; Nishimura K; Honda Y
    Br J Pharmacol; 1999 May; 127(2):537-45. PubMed ID: 10385256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
    Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D
    Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney.
    Klanke B; Simon M; Röckl W; Weich HA; Stolte H; Gröne HJ
    Nephrol Dial Transplant; 1998 Apr; 13(4):875-85. PubMed ID: 9568844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM; Dvorak HF; Brock TA; Senger DR
    Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
    Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
    J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
    Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.
    Ku DD; Zaleski JK; Liu S; Brock TA
    Am J Physiol; 1993 Aug; 265(2 Pt 2):H586-92. PubMed ID: 8368362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.
    van der Zee R; Murohara T; Luo Z; Zollmann F; Passeri J; Lekutat C; Isner JM
    Circulation; 1997 Feb; 95(4):1030-7. PubMed ID: 9054767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vascular permeability factor on the permeability of cultured endothelial cells from brain capillaries.
    Zhao L; Zhang MM; Ng KY
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):1-4. PubMed ID: 9676713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt signaling mediates VEGF/VPF vascular permeability in vivo.
    Six I; Kureishi Y; Luo Z; Walsh K
    FEBS Lett; 2002 Dec; 532(1-2):67-9. PubMed ID: 12459464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M
    Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
    Detmar M; Yeo KT; Nagy JA; Van de Water L; Brown LF; Berse B; Elicker BM; Ledbetter S; Dvorak HF
    J Invest Dermatol; 1995 Jul; 105(1):44-50. PubMed ID: 7615975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.
    Shen H; Clauss M; Ryan J; Schmidt AM; Tijburg P; Borden L; Connolly D; Stern D; Kao J
    Blood; 1993 May; 81(10):2767-73. PubMed ID: 8490183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability.
    Kondo S; Matsumoto T; Yokoyama Y; Ohmori I; Suzuki H
    Biochim Biophys Acta; 1995 Feb; 1243(2):195-202. PubMed ID: 7533000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.
    Feng D; Nagy JA; Hipp J; Dvorak HF; Dvorak AM
    J Exp Med; 1996 May; 183(5):1981-6. PubMed ID: 8642308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.